Akero Therapeutics CEO Andrew Cheng's 2022 pay jumps 135% to $10M
Akero Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
Akero Therapeutics reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, five executives at Akero Therapeutics received on average a compensation package of $5.4M, a 134% increase compared to previous year.
Average pay of disclosed executives at Akero Therapeutics
Andrew Cheng, Chief Executive Officer, received $10M in total, which increased by 135% compared to 2021. 67% of Cheng's compensation, or $7M, was in option awards. Cheng also received $601K in non-equity incentive plan, $624K in salary, as well as $2.2M in stock awards.
For fiscal year 2022, the median employee pay was $515,516 at Akero Therapeutics. Therefore, the ratio of Andrew Cheng's pay to the median employee pay was 20 to one.
Timothy Rolph, DPhil, Chief Scientific Officer, received a compensation package of $4.2M, which increased by 135% compared to previous year. 61% of the compensation package, or $2.6M, was in option awards.
William White, Chief Financial Officer, earned $4.1M in 2022, a 133% increase compared to previous year.
Jonathan Young, Chief Operating Officer, received $4.1M in 2022, which increases by 131% compared to 2021.
Catriona Yale, Chief Development Officer, earned $4.1M in 2022, a 136% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2023.